Precautions When Combining Diclofenac with Anticoagulants

Bleeding Risk

Concomitant use of diclofenac and anticoagulants creates a synergistic effect on bleeding, with a 3-6 fold increased risk of gastrointestinal bleeding compared to using anticoagulants alone 1, 2
The International Normalized Ratio (INR) may increase by up to 15% when NSAIDs are used concurrently with anticoagulants, requiring closer monitoring and potential warfarin dosage adjustments 1

NSAIDs increase the risk of peptic ulceration due to interference with prostaglandin-mediated cytoprotection of the gastrointestinal mucosa, creating potential bleeding sites 3
This interaction is pharmacodynamic rather than pharmacokinetic - no significant pharmacokinetic interaction was demonstrated between dabigatran etexilate and diclofenac 3

If concurrent NSAID and anticoagulant use is absolutely necessary, monitor INR more frequently and adjust warfarin dosage accordingly, as recommended by the American Academy of Family Physicians 2
Initiate gastrointestinal prophylaxis with a proton pump inhibitor (PPI) or misoprostol, as suggested by the American Gastroenterological Association 4, 5
Misoprostol may be preferred over PPIs as it can reduce the risk of both upper and lower GI bleeding, according to the American Gastroenterological Association 5
For patients with serious medical conditions requiring anticoagulation, consider alternative pain management strategies that don't affect coagulation, such as short-term corticosteroids, as recommended by the American Gastroenterological Association 4, 5

Patients with a history of ulcer complications are at particularly high risk and should strictly avoid the combination of NSAIDs and anticoagulants, as advised by the American Gastroenterological Association 4
Elderly patients (>75 years) have a significantly higher risk of serious GI bleeding compared to younger patients, according to the American Academy of Family Physicians 2

Monitor renal function, as impaired renal function can further increase bleeding risk by affecting clearance of both medications 6